[1]
U. Khanna, “AIM HD-CKD study: assessment of the efficacy and safety of ferric carboxymaltose in iron deficiency anemia management in haemodialysis patients with chronic kidney disease”, Int J Clin Trials, vol. 12, no. 2, pp. 80–86, Apr. 2025.